Connection

Peter Verhamme to Double-Blind Method

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Double-Blind Method.
Peter Verhamme
Connection Strength
0.077
Double-Blind Method
  1. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. J Am Coll Cardiol. 2018 05 22; 71(20):2306-2315.
    View in: PubMed
    Score: 0.020
  2. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Thromb Res. 2018 02; 162:7-14.
    View in: PubMed
    Score: 0.020
  3. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2017 12; 117(12):2406-2414.
    View in: PubMed
    Score: 0.019
  4. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med. 2017 03 30; 376(13):1211-1222.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.